
Failures in the generic drug market cost patients millions
Growing evidence suggests that U.S. consumers overpay for generics by as much as 20% while pharmacy benefit managers pad profits, a USC Schaeffer Center white paper finds.
Growing evidence suggests that U.S. consumers overpay for generics by as much as 20% while pharmacy benefit managers pad profits, a USC Schaeffer Center white paper finds.
Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.
Opioid-related deaths among Blacks, Asians and Latinos dropped during the same period, according to a study from USC and the L.A. County Medical Examiner-Coroner’s Office.
One in 10 adults were at risk of overdose, with older Americans relying on high doses of opioids more than younger adults, researchers found in a national sample of prescription claims.
A new approach could help doctors diagnose and treat patients within the critical first hour after an accident.
USC experts search for answers to deadly superbugs.
According to a new USC study, dihydromyricetin — an over-the-counter herbal hangover cure — may also help people cope with alcoholism and liver damage.
Having a wider array of people participating in medical research is crucial to advancing care for all patients.
A new study from the USC Schaeffer Center found that fewer than 5% of state drug pricing laws passed between 2015 and 2018 will provide additional public transparency.
Patients are turning to over-the-counter medications and mind-body therapies to ease pain without narcotics.
Scientists at the USC Michelson Center for Convergent Bioscience and Stanford University take first step toward a safer drug for reducing postpartum bleeding.
For consumers, that could mean soaring costs to purchase some lifesaving drugs, USC study finds.
USC study sheds lights on a practice that occurs more often than we think.
Japanese raisin tree’s leaves may help USC researcher in the fight against Alzheimer’s, Parkinson’s, PTSD, anxiety and other conditions.
USC Schaeffer Center study shows that when clinicians are given information about a patient’s overdose, they prescribe fewer of the powerful painkillers.
Once a shy kid held back by physical disability, Hawken Miller has flourished since becoming an active student at USC.
Some of the recommendations result from work by the USC Leonard Schaeffer Center for Health Policy and Economics.
A new study is a hard look in the mirror for how providers have contributed to the addiction epidemic.
USC Michelson Center scientists are part of an international team developing new alternatives to easing pain in the midst of a national crisis.
USC doctoral student aims to genetically engineer alternatives to meat that taste like the real thing.
The USC Alzheimer’s Therapeutic Institute Director leads the fight to end a disease that affects millions.
USC experts say cash prices for medication can vary widely in the same neighborhood. But few comparison shop for health care.
Paul Bogdan examines pharmaceuticals as if they were people who interact in a social network.
Hospitals with higher rates of opioid prescription also had the best ratings for pain management, study finds.